Literature DB >> 12099291

Gelatinases in soft tissue biomaterials. Analysis of different crosslinking agents.

P Calero1, E Jorge-Herrero, J Turnay, N Olmo, I López de Silanes, M A Lizarbe, M Martín Maestro, B Arenaz, J L Castillo-Olivares.   

Abstract

Chemical modification of pericardium-based cardiac valves tends to reduce the relatively high degree of biodegradation and calcification of the implanted bioprostheses. We analysed the tissue properties of pericardium from young calves and pigs after crosslinking with different agents (glutaraldehyde. diphenylphosphorylazide (DDPA), 1-ethyl-3,3-dimethyl-aminopropyl-carbodiimide (EDAC)) and when exposed to anticalcification treatments (chloroform/methanol or ethanol) prior to glutaraldehyde (GA) crosslinking. Protein extraction after tissue homogenisation in the presence of detergents showed that crosslinking using GA or DPPA was much more effective. The amounts of protein extracted from these two groups of chemically modified pericardium were significantly lower: the other modified tissues presented only a slight reduction when compared with untreated tissue. Matrix metalloproteinases- (MMP) 2 and 9 were detected in native pericardium from calf and pig by zymography. While the MMP-9/MMP-2 activity ratio was close to 1 in pig pericardium, it was 8.5-fold higher in bovine tissue. Crosslinking with GA and with DPPA almost completely abolished gelatinase activities, even when equal amounts of solubilised protein were loaded onto the zymograms. Anticalcification treatments followed by GA crosslinking or treatment with EDAC were not as effective in reducing gelatinase activities; but, interestingly, a relative reduction of MMP-9 versus MMP-2 was detected. The presence of these gelatinase activities in pericardium may contribute to the in vivo degradability of pericardium-based cardiac valves.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099291     DOI: 10.1016/s0142-9612(02)00054-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  The inhibitory effect of polyvinylphosphonic acid on functional matrix metalloproteinase activities in human demineralized dentin.

Authors:  Arzu Tezvergil-Mutluay; Kelli A Agee; Tomohiro Hoshika; Franklin R Tay; David H Pashley
Journal:  Acta Biomater       Date:  2010-05-23       Impact factor: 8.947

2.  Activity of MMP-9 after repair of abdominal wall defects with acellular and crosslinked bovine pericardium in rabbit.

Authors:  Himani Singh; Naveen Kumar; A K Sharma; Meena Kataria; Ashok Munjal; Amit Kumar; Rukmani Dewangan; Vineet Kumar; J Devarathnam; Sachin Kumar
Journal:  Int Wound J       Date:  2012-06-22       Impact factor: 3.315

Review 3.  Limitations in bonding to dentin and experimental strategies to prevent bond degradation.

Authors:  Y Liu; L Tjäderhane; L Breschi; A Mazzoni; N Li; J Mao; D H Pashley; F R Tay
Journal:  J Dent Res       Date:  2011-01-10       Impact factor: 6.116

4.  Carbodiimide cross-linking inactivates soluble and matrix-bound MMPs, in vitro.

Authors:  A Tezvergil-Mutluay; M M Mutluay; K A Agee; R Seseogullari-Dirihan; T Hoshika; M Cadenaro; L Breschi; P Vallittu; F R Tay; D H Pashley
Journal:  J Dent Res       Date:  2011-11-04       Impact factor: 6.116

5.  Carbodiimide inactivation of MMPs and effect on dentin bonding.

Authors:  A Mazzoni; F M Apolonio; V P A Saboia; S Santi; V Angeloni; V Checchi; R Curci; R Di Lenarda; F R Tay; D H Pashley; L Breschi
Journal:  J Dent Res       Date:  2013-12-11       Impact factor: 6.116

6.  Characterization of biomodified dentin matrices for potential preventive and reparative therapies.

Authors:  Ana Karina B Bedran-Russo; Carina S Castellan; Mirela S Shinohara; Lina Hassan; Alberto Antunes
Journal:  Acta Biomater       Date:  2010-12-16       Impact factor: 8.947

7.  Atomic force microscopy investigation of chemically stabilized pericardium tissue.

Authors:  M Jastrzebska; B Barwinski; I Mróz; A Turek; J Zalewska-Rejdak; B Cwalina
Journal:  Eur Phys J E Soft Matter       Date:  2005-04       Impact factor: 1.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.